Evidence map›Paper›PMID 34348121›Full record

ArticleCancer cell2021

Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.

Sidse Ehmsen, Anders Asmussen, Stefan S Jeppesen, Anna Christine Nilsson, Sabina Østerlev, Hanne Vestergaard, Ulrik S Justesen, Isik S Johansen, Henrik Frederiksen, Henrik J Ditzel

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Pooled it
  11. Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.Annals of oncology : official journal of the European Society for Medical Oncology · 2022
    Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. TClinical and translational medicine · 2022
    Trial
  16. Article
  17. Article
  18. Article
  19. Review
  20. Observational

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Sidse EhmsenDepartment of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Oncology, Odense University Hospital, Odense, Denmark.
Anders AsmussenDepartment of Hematology, Odense University Hospital, Odense, Denmark.
Stefan S JeppesenDepartment of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Oncology, Odense University Hospital, Odense, Denmark.
Anna Christine NilssonDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Sabina ØsterlevDepartment of Oncology, Odense University Hospital, Odense, Denmark.
Hanne VestergaardDepartment of Hematology, Odense University Hospital, Odense, Denmark.
Ulrik S JustesenDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
Isik S JohansenDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Infectious Disease, Odense University Hospital, Odense, Denmark.
Henrik FrederiksenDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Oncology, Odense University Hospital, Odense, Denmark; Department of Hematology, Odense University Hospital, Odense, Denmark.
Henrik J DitzelDepartment of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Oncology, Odense University Hospital, Odense, Denmark; OPEN-Open Patient data Exploratory Network, Odense University Hospital, Odense, Denmark; Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark. Electronic address: hditzel@health.sdu.dk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunityVaccinationCOVID-19COVID-19 VaccinesHost-Pathogen InteractionsHumansImmunity, CellularImmunity, HumoralImmunogenicity, VaccinemRNA VaccinesSARS-CoV-2Vaccines, SyntheticCOVID-19 VaccinesmRNA VaccinesVaccines, Synthetic

Identifiers

PMID34348121
PMCPMC8313483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.